| Autor: |
Buck SAJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands. s.buck@erasmusmc.nl., Guchelaar NAD; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Ghobadi Moghaddam-Helmantel IM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Mathijssen-van Stein D; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Dr Molewaterplein 40, 3015GD, Rotterdam, The Netherlands. |
Full text from SpringerLink